{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:56:44Z","timestamp":1790146604768,"version":"4.0.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s11904-014-0254-4","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T12:48:35Z","timestamp":1422881315000},"page":"6-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Human Papillomavirus in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era"],"prefix":"10.1007","volume":"12","author":[{"given":"Cristina","family":"Brickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Palefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"issue":"Suppl 3","key":"254_CR1","first-page":"S3\/106","volume":"24","author":"M Stanley","year":"2006","unstructured":"Stanley M, Lowy DR, Frazer I. Chapter 12: prophylactic HPV vaccines: underlying mechanisms. Vaccine. 2006;24 Suppl 3:S3\/106\u201313.","journal-title":"Vaccine"},{"issue":"9590","key":"254_CR2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M et al. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907.","journal-title":"Lancet"},{"key":"254_CR3","first-page":"258","volume":"61","author":"Centers for Disease, C. and Prevention","year":"2012","unstructured":"Centers for Disease, C. and Prevention. Human papillomavirus-associated cancers\u2014United States, 2004\u20132008. MMWR Morb Mortal Wkly Rep. 2012;61:258\u201361.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"254_CR4","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/djp205","volume":"101","author":"AK Chaturvedi","year":"2009","unstructured":"Chaturvedi AK et al. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101(16):1120\u201330.","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"254_CR5","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","volume":"92","author":"M Frisch","year":"2000","unstructured":"Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92(18):1500\u201310.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"254_CR6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","volume":"148","author":"P Patel","year":"2008","unstructured":"Patel P et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992\u20132003. Ann Intern Med. 2008;148(10):728\u201336.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"254_CR7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/QAI.0b013e31825a3668","volume":"60","author":"KP High","year":"2012","unstructured":"High KP et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60 Suppl 1:S1\u201318.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"254_CR8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621\u201332.","journal-title":"Int J Cancer"},{"key":"254_CR9","unstructured":"Ferlay J, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No.11 [Internet]. 2012; Available from: http:\/\/globocan.iarc.fr , accessed on 11\/28\/2014."},{"key":"254_CR10","unstructured":"Howlader N, et al. SEER Cancer Statistics Review, 1975\u20132011, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2011\/ , based on November 2013 SEER data submission, posted to the SEER web site, April 2014. 2014; Available from: http:\/\/seer.cancer.gov\/csr\/1975_2011\/ ."},{"issue":"4","key":"254_CR11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","volume":"120","author":"International Collaboration of Epidemiological Studies of Cervical, C","year":"2007","unstructured":"International Collaboration of Epidemiological Studies of Cervical, C. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2007;120(4):885\u201391.","journal-title":"Int J Cancer"},{"issue":"RR-17","key":"254_CR12","first-page":"1","volume":"41","author":"KG Castro","year":"1992","unstructured":"Castro KG et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1\u201319.","journal-title":"MMWR Recomm Rep"},{"issue":"16","key":"254_CR13","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.2005.05.4908","volume":"24","author":"M Bower","year":"2006","unstructured":"Bower M, Mazhar D, Stebbing J. Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer? J Clin Oncol. 2006;24(16):2417\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"254_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","volume":"97","author":"GM Clifford","year":"2005","unstructured":"Clifford GM et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425\u201332.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"254_CR15","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/cid\/cit497","volume":"57","author":"M Hleyhel","year":"2013","unstructured":"Hleyhel M et al. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. Clin Infect Dis. 2013;57(11):1638\u201347. Data from large French HIV cohort that summarizes the most recent incidence trends of AIDS-defining malignancies.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"254_CR16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ijc.21443","volume":"118","author":"SM Mbulaiteye","year":"2006","unstructured":"Mbulaiteye SM et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006;118(4):985\u201390.","journal-title":"Int J Cancer"},{"issue":"10","key":"254_CR17","doi-asserted-by":"crossref","first-page":"e48108","DOI":"10.1371\/journal.pone.0048108","volume":"7","author":"A Tanon","year":"2012","unstructured":"Tanon A et al. The spectrum of cancers in West Africa: associations with human immunodeficiency virus. PLoS One. 2012;7(10):e48108.","journal-title":"PLoS One"},{"issue":"1","key":"254_CR18","doi-asserted-by":"crossref","first-page":"e8621","DOI":"10.1371\/journal.pone.0008621","volume":"5","author":"AJ Sasco","year":"2010","unstructured":"Sasco AJ et al. The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One. 2010;5(1):e8621.","journal-title":"PLoS One"},{"issue":"2","key":"254_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10552-007-9080-y","volume":"19","author":"AA Dhir","year":"2008","unstructured":"Dhir AA et al. Spectrum of HIV\/AIDS related cancers in India. Cancer Causes Control. 2008;19(2):147\u201353.","journal-title":"Cancer Causes Control"},{"issue":"12","key":"254_CR20","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","volume":"10","author":"M Guiguet","year":"2009","unstructured":"Guiguet M et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009;10(12):1152\u20139.","journal-title":"Lancet Oncol"},{"issue":"12","key":"254_CR21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","volume":"99","author":"RJ Biggar","year":"2007","unstructured":"Biggar RJ et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99(12):962\u201372.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"254_CR22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjc.6605756","volume":"103","author":"S Franceschi","year":"2010","unstructured":"Franceschi S et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103(3):416\u201322.","journal-title":"Br J Cancer"},{"issue":"9","key":"254_CR23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","volume":"103","author":"MS Shiels","year":"2011","unstructured":"Shiels MS et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103(9):753\u201362.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"254_CR24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24215","volume":"124","author":"BE Hoots","year":"2009","unstructured":"Hoots BE et al. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124(10):2375\u201383.","journal-title":"Int J Cancer"},{"issue":"4","key":"254_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/LGT.0b013e31827ed372","volume":"17","author":"M Steinau","year":"2013","unstructured":"Steinau M et al. Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis. 2013;17(4):397\u2013403. Used SEER registry to identify and perform HPV testing on anal cancer specimens. 90% of anal cancers are associated with HPV-infection, primarily HPV-16.","journal-title":"J Low Genit Tract Dis"},{"key":"254_CR26","unstructured":"Darragh T, et al. The anal canal and perianus: HPV-related disease, in modern colposcopy: textbook and atlas E.J. Mayeaux and J. Thomas Cox, Editors. 2012, Lippincott, Williams, & Wilkins: Baltimore."},{"issue":"1","key":"254_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bjc.6603175","volume":"95","author":"DH Brewster","year":"2006","unstructured":"Brewster DH, Bhatti LA. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975\u20132002. Br J Cancer. 2006;95(1):87\u201390.","journal-title":"Br J Cancer"},{"issue":"3","key":"254_CR28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.bjc.6604871","volume":"100","author":"D Robinson","year":"2009","unstructured":"Robinson D, Coupland V, Moller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer. 2009;100(3):527\u201331.","journal-title":"Br J Cancer"},{"issue":"5","key":"254_CR29","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/ijc.26115","volume":"130","author":"A Nielsen","year":"2012","unstructured":"Nielsen A, Munk C, Kjaer SK. Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978\u20132008. Int J Cancer. 2012;130(5):1168\u201373.","journal-title":"Int J Cancer"},{"issue":"12","key":"254_CR30","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.vaccine.2011.01.015","volume":"29","author":"F Jin","year":"2011","unstructured":"Jin F et al. Trends in anal cancer in Australia, 1982\u20132005. Vaccine. 2011;29(12):2322\u20137.","journal-title":"Vaccine"},{"issue":"8","key":"254_CR31","first-page":"401","volume":"71","author":"RP Zee van der","year":"2013","unstructured":"van der Zee RP et al. The increasing incidence of anal cancer: can it be explained by trends in risk groups? Neth J Med. 2013;71(8):401\u201311.","journal-title":"Neth J Med"},{"issue":"14","key":"254_CR32","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.1982.03320390050042","volume":"247","author":"JR Daling","year":"1982","unstructured":"Daling JR et al. Correlates of homosexual behavior and the incidence of anal cancer. JAMA. 1982;247(14):1988\u201390.","journal-title":"JAMA"},{"issue":"16","key":"254_CR33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM198710153171601","volume":"317","author":"JR Daling","year":"1987","unstructured":"Daling JR et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317(16):973\u20137.","journal-title":"N Engl J Med"},{"issue":"19","key":"254_CR34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","volume":"337","author":"M Frisch","year":"1997","unstructured":"Frisch M et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337(19):1350\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"254_CR35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/AOG.0b013e31820bfb16","volume":"117","author":"AM Saleem","year":"2011","unstructured":"Saleem AM et al. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol. 2011;117(3):643\u20139.","journal-title":"Obstet Gynecol"},{"issue":"35","key":"254_CR36","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1200\/JCO.2012.44.5486","volume":"30","author":"C Piketty","year":"2012","unstructured":"Piketty C et al. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol. 2012;30(35):4360\u20136. Data from large French HIV cohort that summarizes recent incidence trends for anal cancer in HIV-infected patients.","journal-title":"J Clin Oncol"},{"issue":"7","key":"254_CR37","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cir1012","volume":"54","author":"MJ Silverberg","year":"2012","unstructured":"Silverberg MJ et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012;54(7):1026\u201334. Recent incidence rates of anal cancer among HIV-infected patients in the US.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"254_CR38","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","volume":"20","author":"MJ Silverberg","year":"2011","unstructured":"Silverberg MJ et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(12):2551\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"254_CR39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QAD.0b013e328331f6e2","volume":"24","author":"NF Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone NF et al. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS. 2010;24(4):535\u201343.","journal-title":"AIDS"},{"issue":"20","key":"254_CR40","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/jnci\/djs371","volume":"104","author":"MS Shiels","year":"2012","unstructured":"Shiels MS et al. Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst. 2012;104(20):1591\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"254_CR41","unstructured":"Prevention, C.f.D.C.a. HIV surveillance report, 2011. 2013 November 28 2013]; Available from: http:\/\/www.cdc.gov\/hiv\/topics\/surveillance\/resources\/reports\/ ."},{"issue":"6","key":"254_CR42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/aje\/kwt153","volume":"178","author":"B Bertisch","year":"2013","unstructured":"Bertisch B et al. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol. 2013;178(6):877\u201384.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"254_CR43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAI.0b013e3182968fa7","volume":"63","author":"EY Chiao","year":"2013","unstructured":"Chiao EY et al. The impact of HIV viral control on the incidence of HIV-associated anal cancer. J Acquir Immune Defic Syndr. 2013;63(5):631\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3 Suppl 1","key":"254_CR44","first-page":"S2","volume":"106","author":"BA Weaver","year":"2006","unstructured":"Weaver BA. Epidemiology and natural history of genital human papillomavirus infection. J Am Osteopath Assoc. 2006;106(3 Suppl 1):S2\u20138.","journal-title":"J Am Osteopath Assoc"},{"issue":"8","key":"254_CR45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","volume":"297","author":"EF Dunne","year":"2007","unstructured":"Dunne EF et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813\u20139.","journal-title":"JAMA"},{"issue":"12","key":"254_CR46","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1086\/425906","volume":"190","author":"PV Chin-Hong","year":"2004","unstructured":"Chin-Hong PV et al. Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis. 2004;190(12):2070\u20136.","journal-title":"J Infect Dis"},{"issue":"11 Pt 1","key":"254_CR47","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/1055-9965.EPI-05-0460","volume":"14","author":"BY Hernandez","year":"2005","unstructured":"Hernandez BY et al. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2550\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"254_CR48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007435-200208000-00001","volume":"29","author":"MJ Silverberg","year":"2002","unstructured":"Silverberg MJ et al. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis. 2002;29(8):427\u201335.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"254_CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00126334-199905010-00005","volume":"21","author":"LS Massad","year":"1999","unstructured":"Massad LS et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr. 1999;21(1):33\u201341.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"254_CR50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","volume":"91","author":"JM Palefsky","year":"1999","unstructured":"Palefsky JM et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91(3):226\u201336.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"254_CR51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mob.2002.119776","volume":"186","author":"DJ Jamieson","year":"2002","unstructured":"Jamieson DJ et al. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol. 2002;186(1):21\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"254_CR52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/427777","volume":"191","author":"DH Watts","year":"2005","unstructured":"Watts DH et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005;191(7):1129\u201339.","journal-title":"J Infect Dis"},{"issue":"7","key":"254_CR53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/597207","volume":"199","author":"A Pokomandy de","year":"2009","unstructured":"de Pokomandy A et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis. 2009;199(7):965\u201373.","journal-title":"J Infect Dis"},{"issue":"10","key":"254_CR54","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1086\/656775","volume":"202","author":"L Conley","year":"2010","unstructured":"Conley L et al. Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis. 2010;202(10):1567\u201376.","journal-title":"J Infect Dis"},{"issue":"3","key":"254_CR55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","volume":"183","author":"JM Palefsky","year":"2001","unstructured":"Palefsky JM et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis. 2001;183(3):383\u201391.","journal-title":"J Infect Dis"},{"issue":"6","key":"254_CR56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-138-6-200303180-00008","volume":"138","author":"C Piketty","year":"2003","unstructured":"Piketty C et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 2003;138(6):453\u20139.","journal-title":"Ann Intern Med"},{"issue":"10","key":"254_CR57","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/652187","volume":"201","author":"AG Nyitray","year":"2010","unstructured":"Nyitray AG et al. Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis. 2010;201(10):1498\u2013508.","journal-title":"J Infect Dis"},{"issue":"8","key":"254_CR58","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jnci\/dji073","volume":"97","author":"HD Strickler","year":"2005","unstructured":"Strickler HD et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97(8):577\u201386. First study to show that newly detected HPV infection occurs in celibate women, suggesting the reactivation of previously latent HPV infection.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"254_CR59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/322856","volume":"184","author":"FB Lillo","year":"2001","unstructured":"Lillo FB et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis. 2001;184(5):547\u201351.","journal-title":"J Infect Dis"},{"issue":"5","key":"254_CR60","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/381681","volume":"38","author":"A Mistro Del","year":"2004","unstructured":"Del Mistro A et al. Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women. Clin Infect Dis. 2004;38(5):737\u201342.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"254_CR61","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00042560-200112150-00003","volume":"28","author":"JM Palefsky","year":"2001","unstructured":"Palefsky JM et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr. 2001;28(5):422\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"254_CR62","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/infdis\/jit090","volume":"207","author":"D Konopnicki","year":"2013","unstructured":"Konopnicki D et al. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women. J Infect Dis. 2013;207(11):1723\u20139. Large cohort study of HIV-infected women with extended follow-up time. Shows very limited effect of ART in decreasing the risk of persistent cervical hr-HPV infection.","journal-title":"J Infect Dis"},{"issue":"3","key":"254_CR63","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/infdis\/jit181","volume":"208","author":"S Blitz","year":"2013","unstructured":"Blitz S et al. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis. 2013;208(3):454\u201362. Additional recent large cohort of HIV-infected women with extended follow-up time. Shows limited effect of ART in promoting regression of SIL.","journal-title":"J Infect Dis"},{"issue":"5","key":"254_CR64","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/650467","volume":"201","author":"H Minkoff","year":"2010","unstructured":"Minkoff H et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis. 2010;201(5):681\u201390.","journal-title":"J Infect Dis"},{"issue":"7","key":"254_CR65","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/OLQ.0b013e31825aa764","volume":"39","author":"EM Snoek van der","year":"2012","unstructured":"van der Snoek EM et al. Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men. Sex Transm Dis. 2012;39(7):495\u2013500.","journal-title":"Sex Transm Dis"},{"key":"254_CR66","doi-asserted-by":"crossref","unstructured":"The 1988 Bethesda System for reporting cervical\/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA, 1989. 262(7): p. 931\u20134.","DOI":"10.1001\/jama.1989.03430070079034"},{"issue":"3","key":"254_CR67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","volume":"16","author":"TM Darragh","year":"2012","unstructured":"Darragh TM et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16(3):205\u201342. Describes the Lower Anogenital Terminology Standardization (LAST) project and new proposed terminology to classify HPV lesion.","journal-title":"J Low Genit Tract Dis"},{"key":"254_CR68","unstructured":"Wright TC, Kurman RJ, and Ferenczy A. Precancerous lesions of the cervix, in Blaustein\u2019s pathology of the female genital tract, Kurman RJ, Editor. 2002, Springer-Verlag: New York City. p. 277."},{"issue":"7","key":"254_CR69","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","volume":"100","author":"AC Rodriguez","year":"2008","unstructured":"Rodriguez AC et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst. 2008;100(7):513\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"254_CR70","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","volume":"120","author":"Committee on Practice, B.-G","year":"2012","unstructured":"Committee on Practice, B.-G. ACOG practice bulletin number 131: screening for cervical cancer. Obstet Gynecol. 2012;120(5):1222\u201338.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"254_CR71","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mob.2001.111791","volume":"184","author":"A Duerr","year":"2001","unstructured":"Duerr A et al. Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol. 2001;184(4):584\u201390.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"254_CR72","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1258\/095646202320753727","volume":"13","author":"ZM Chirenje","year":"2002","unstructured":"Chirenje ZM et al. Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV\/STI prevention study. Int J STD AIDS. 2002;13(11):765\u20138.","journal-title":"Int J STD AIDS"},{"issue":"8","key":"254_CR73","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","volume":"283","author":"TV Ellerbrock","year":"2000","unstructured":"Ellerbrock TV et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031\u20137.","journal-title":"JAMA"},{"issue":"13","key":"254_CR74","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.aids.0000181012.62385.4a","volume":"19","author":"JM Palefsky","year":"2005","unstructured":"Palefsky JM et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS. 2005;19(13):1407\u201314.","journal-title":"AIDS"},{"issue":"5","key":"254_CR75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.7326\/0003-4819-149-5-200809020-00004","volume":"149","author":"PV Chin-Hong","year":"2008","unstructured":"Chin-Hong PV et al. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med. 2008;149(5):300\u20136.","journal-title":"Ann Intern Med"},{"issue":"1","key":"254_CR76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/QAD.0b013e32831cc101","volume":"23","author":"NA Hessol","year":"2009","unstructured":"Hessol NA et al. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS. 2009;23(1):59\u201370.","journal-title":"AIDS"},{"issue":"4","key":"254_CR77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/OLQ.0b013e3181f70253","volume":"38","author":"EM Kojic","year":"2011","unstructured":"Kojic EM et al. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV\/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis. 2011;38(4):253\u20139.","journal-title":"Sex Transm Dis"},{"issue":"7","key":"254_CR78","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/OLQ.0b013e31825f7921","volume":"39","author":"JM Palefsky","year":"2012","unstructured":"Palefsky JM. Antiretroviral therapy and anal cancer: the good, the bad, and the unknown. Sex Transm Dis. 2012;39(7):501\u20133.","journal-title":"Sex Transm Dis"},{"issue":"9","key":"254_CR79","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/cid\/cir064","volume":"52","author":"A Pokomandy de","year":"2011","unstructured":"de Pokomandy A et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis. 2011;52(9):1174\u201381.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"254_CR80","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jama.2014.8722","volume":"312","author":"HF Gunthard","year":"2014","unstructured":"Gunthard HF et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA. 2014;312(4):410\u201325.","journal-title":"JAMA"},{"issue":"5","key":"254_CR81","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"MR McCredie","year":"2008","unstructured":"McCredie MR et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425\u201334. Describes New Zealand study that quantified risk of cervical HSIL progression in HIV-uninfected women.","journal-title":"Lancet Oncol"},{"issue":"3","key":"254_CR82","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","volume":"91","author":"P Holowaty","year":"1999","unstructured":"Holowaty P et al. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999;91(3):252\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"254_CR83","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(12)70080-3","volume":"13","author":"DA Machalek","year":"2012","unstructured":"Machalek DA et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13(5):487\u2013500. Uses data from meta-analysis to estimate yearly risk of developing anal cancer among HIV-infected and HIV-uninfected MSM with HSIL.","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"254_CR84","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jcv.2004.12.006","volume":"32","author":"J Doorbar","year":"2005","unstructured":"Doorbar J. The papillomavirus life cycle. J Clin Virol. 2005;32 Suppl 1:S7\u201315.","journal-title":"J Clin Virol"},{"issue":"3","key":"254_CR85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tim.2010.12.006","volume":"19","author":"M Herfs","year":"2011","unstructured":"Herfs M et al. Mucosal junctions: open doors to HPV and HIV infections? Trends Microbiol. 2011;19(3):114\u201320.","journal-title":"Trends Microbiol"},{"key":"254_CR86","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.2741\/1971","volume":"11","author":"ZM Zheng","year":"2006","unstructured":"Zheng ZM, Baker CC. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci. 2006;11:2286\u2013302.","journal-title":"Front Biosci"},{"issue":"7","key":"254_CR87","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1128\/JVI.71.7.5540-5548.1997","volume":"71","author":"R Selvakumar","year":"1997","unstructured":"Selvakumar R et al. Regression of papillomas induced by cottontail rabbit papillomavirus is associated with infiltration of CD8+ cells and persistence of viral DNA after regression. J Virol. 1997;71(7):5540\u20138.","journal-title":"J Virol"},{"issue":"2","key":"254_CR88","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virol.2011.03.019","volume":"414","author":"GA Maglennon","year":"2011","unstructured":"Maglennon GA, McIntosh P, Doorbar J. Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology. 2011;414(2):153\u201363.","journal-title":"Virology"},{"issue":"7488","key":"254_CR89","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12881","volume":"506","author":"AI Ojesina","year":"2014","unstructured":"Ojesina AI et al. Landscape of genomic alterations in cervical carcinomas. Nature. 2014;506(7488):371\u20135.","journal-title":"Nature"},{"issue":"2","key":"254_CR90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2010.01.034","volume":"400","author":"L Barrow-Laing","year":"2010","unstructured":"Barrow-Laing L, Chen W, Roman A. Low- and high-risk human papillomavirus E7 proteins regulate p130 differently. Virology. 2010;400(2):233\u20139.","journal-title":"Virology"},{"issue":"6","key":"254_CR91","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1007\/s13277-014-1737-z","volume":"35","author":"J Fang","year":"2014","unstructured":"Fang J, Zhang H, Jin S. Epigenetics and cervical cancer: from pathogenesis to therapy. Tumour Biol. 2014;35(6):5083\u201393.","journal-title":"Tumour Biol"},{"issue":"1\u20132","key":"254_CR92","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.virol.2013.08.018","volume":"446","author":"SM Tugizov","year":"2013","unstructured":"Tugizov SM et al. HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology. 2013;446(1\u20132):378\u201388. In vitro study that shows how HIV-derived tat and gp120 disrupt epithelial tight-cell junctions which allow HPV pseudovirion infection of the basal cell l epithelium.","journal-title":"Virology"},{"key":"254_CR93","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1479-5876-7-108","volume":"7","author":"SH Burg van der","year":"2009","unstructured":"van der Burg SH, Palefsky JM. Human immunodeficiency virus and human papilloma virus\u2014why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med. 2009;7:108.","journal-title":"J Transl Med"},{"issue":"1","key":"254_CR94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mi.2007.1","volume":"1","author":"JM Brenchley","year":"2008","unstructured":"Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1(1):23\u201330.","journal-title":"Mucosal Immunol"},{"issue":"8","key":"254_CR95","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/infdis\/jiq172","volume":"203","author":"RG Nowak","year":"2011","unstructured":"Nowak RG et al. Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe. J Infect Dis. 2011;203(8):1182\u201391. Cohort study showing a rapid rise in cervical HPV infection soon after HIV infection. Argues that immune dysregulation associated with acute HIV leads to the reactivation of previously latent HPV.","journal-title":"J Infect Dis"},{"issue":"4","key":"254_CR96","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/infdis\/jiq083","volume":"203","author":"C Wang","year":"2011","unstructured":"Wang C et al. Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. J Infect Dis. 2011;203(4):479\u201386. Cohort study showing a rapid rise in cervical HPV infection soon after HIV infection. Argues that immune dysregulation associated with acute HIV leads to the reactivation of previously latent HPV.","journal-title":"J Infect Dis"},{"issue":"1","key":"254_CR97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/COH.0000000000000025","volume":"9","author":"AH Borges","year":"2014","unstructured":"Borges AH, Dubrow R, Silverberg MJ. Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk. Curr Opin HIV AIDS. 2014;9(1):34\u201340.","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-014-0254-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-014-0254-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-014-0254-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T04:26:39Z","timestamp":1651119999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-014-0254-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1007\/s11904-014-0254-4","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}